Positron Emission Tomography in Oncology
- Council on Scientific Affairs Report of the Positron Emission Tomography Panel;
- George M. Bohigian, MD;
- E. Harvey Estes, Jr, MD;
- Ira R. Friedlander, MD;
- William R. Kennedy, MD;
- John H. Moxley III, MD;
- Patricia J. Numann, MD;
- Paul S. Salva, PhD;
- William C. Scott, MD;
- Joseph H. Skom, MD;
- Richard M. Steinhilber, MD;
- Jack P. Strong, MD;
- Henry H. Wagner, Jr, MD;
- William R. Hendee, PhD;
- William T. McGivney, PhD;
- Joanna S. Fowler, PhD;
- Edward J. Hoffman, PhD;
- Steven M. Larson, MD;
- Heinrich R. Schelbert, MD;
- Markus Schwaiger, MD;
- Henry N. Wagner, Jr, MD;
- Alfred P. Wolf, PhD;
- Paul K. Strudler, PhD;
- William R. Hendee, PhD;
- Theodore C. Doege, MD, MS
- St Louis, Chairman; Chicago, Resident Representative; Minneapolis; Los Angeles, Immediate Past Chairman; Syracuse, NY; Lubbock, Tex, Medical Student Representative; Tucson, Vice-Chairman; Chicago; Cleveland; New Orleans; Baltimore; Upton, NY; Los Angeles; Bethesda, Md; Los Angeles; Los Angeles; Baltimore, Council on Scientific Affairs Liaison; Upton, NY
- From the Council on Scientific Affairs, American Medical Association, Chicago.
Abstract
This report describes the current and potential uses of positron emission tomography in clinical medicine and research related to oncology. Assessment will be possible of metabolism and physiology of tumors and their effects on adjacent tissues. Specific probes are likely to be developed for target sites on tumors, including monoclonal antibodies and specific growth factors that recognize tumors. To date, most oncological applications of positron emission tomography tracers have been qualitative; in the future, quantitative metabolic measurements should aid in the evaluation of tumor biology and response to treatment.
(JAMA 1988;259:2126-2131)
Footnotes
-
This report was submitted to the House of Delegates at the 1987 Annual Meeting as an informational report.
-
This report is not intended to be construed or to serve as a standard of medical care. Standards of medical care are determined on the basis of all of the facts and circumstances involved in an individual case and are subject to change as scientific knowledge and technology advance and patterns of practice evolve. This report reflects the views of scientific literature as of February 1987.
-
Reprint requests to Council on Scientific Affairs, American Medical Association, 535 N Dearborn St, Chicago, IL 60610 (William R. Hendee, PhD).
